In re Freeman’s Empirical Analysis
474 F.2d 1318 · 1973
Citation profile
1 district ·
How this case has been cited
Cited by 14 later decisions — most recently February 2013
1 district ·
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 35 U.S.C. § 103
Relies on Kropa v. Robie · In re Sinex · In re De Montmollin · In re Garfinkel · In re Murch
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 14 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“In order for a showing of “unexpected results” to be probative evidence of non-obviousness, it falls upon the applicant to at least establish: (1) that there actually is a difference between the results obtained through the claimed invention and those of the prior art, In re Klosak, 455 F.2d 1077 , 59 CCPA 862 (1972); and (2) that the difference actually obtained would not have been expected by one skilled in the art at the time of invention, Id.; In re D’Ancicco, 439 F.2d 1244 , 58 CCPA 1057 (1971).”
1 later decision quote this exact passagee.g. In re Juillard“is strong enough to establish a prima facie case, i.e., one which would prevail in the absence of rebuttal evidence, we must go on to examine the evidence of non-obviousness before the legal conclusion called for by section 103 can be reached.”
1 later decision quote this exact passagee.g. In re Dillon“We have recently pointed out that the rule derived from Mod and de Montmol-lin by the Patent Office is not supported by those cases.”
1 later decision quote this exact passagee.g. In re Dillon
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.